Literature DB >> 25900253

Appearance of hepatocellular carcinoma on gadoxetic acid-enhanced hepato-biliary phase MR imaging: a systematic review.

Paola Erra1, Marta Puglia1, Alfonso Ragozzino2, Simone Maurea1, Raffaele Liuzzi3, Giuseppe Sabino1, Luigi Barbuto1, Alberto Cuocolo1, Massimo Imbriaco4,5.   

Abstract

OBJECTIVE: To perform a systematic review of the contrast behaviour of HCC on Gd-EOB-DTPA hepato-biliary phase MRI.
MATERIALS AND METHODS: This review was completed in accordance with the recommendations outlined in the preferred reporting items for systematic reviews statement. In all reports, qualitative analysis of signal intensity (SI) of HCC on hepato-biliary phase was performed: the relative SI of HCC. When available, a quantitative analysis of tumour enhancement was evaluated.
RESULTS: A total of 106 studies were retrieved, of which 41 met the inclusion criteria. The total number of patients was 2550, with 3132 HCC. MRI showed 3110 HCC (22 non-detected). 2692/3110 (87 %) HCC were hypointense on Gd-EOB-DTPA-enhanced hepatocyte-phase MRI, 134 (4 %) isointense; 106 (3 %) hyperintense and 178 (6 %) iso-hyperintense. In 26 articles, 1653 HCCs were classified as follows: 519 well-differentiated, 883 moderately differentiated, 251 poorly differentiated. Among well-differentiated HCC, 445 (86 %) were hypointense, 12 isointense (2 %), 9 hyperintense (2 %), 53 iso/hyperintense (10 %). Among moderately differentiated HCC, 774 (88 %) were hypointense, 8 isointense (1 %), 27 hyperintense (3 %), 74 iso/hyperintense (8 %). Among poorly differentiated HCCs, 245 (98 %) were hypointense, one isointense, one hyperintense and four iso-hyperintense (2 %). We found a Chi-square (χ (2)) equivalent to 25,082 (p < 0.001).
CONCLUSION: The percentage of lesions iso/hyper/iso-hyper is the same when considering well-differentiated and moderately differentiated HCC; when considering poorly differentiated HCC, the percentage of lesions iso/hyper/iso-hyper is significantly lower. Conversely, the percentage of lesions hypointense is significantly more represented in poorly differentiated HCC compared to well-differentiated and moderately differentiated HCC.

Entities:  

Keywords:  Contrast medium; HCC; Liver

Mesh:

Substances:

Year:  2015        PMID: 25900253     DOI: 10.1007/s11547-015-0539-8

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  56 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  Contribution of the hepatobiliary phase of Gd-EOB-DTPA-enhanced MRI to Dynamic MRI in the detection of hypovascular small (≤ 2 cm) HCC in cirrhosis.

Authors:  Rita Golfieri; Matteo Renzulli; Vincenzo Lucidi; Beniamino Corcioni; Franco Trevisani; Luigi Bolondi
Journal:  Eur Radiol       Date:  2011-02-05       Impact factor: 5.315

3.  Contrast enhancement with Gd-EOB-DTPA in MR imaging of hepatocellular carcinoma in mice: a comparison with superparamagnetic iron oxide.

Authors:  M Fujita; R Yamamoto; B Fritz-Zieroth; T Yamanaka; M Takahashi; T Miyazawa; M Tatsuta; N Terada; N Hosomi; E Inoue; C Kuroda
Journal:  J Magn Reson Imaging       Date:  1996 May-Jun       Impact factor: 4.813

4.  Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.

Authors:  Utaroh Motosugi; Tomoaki Ichikawa; Hironobu Sou; Katsuhiro Sano; Licht Tominaga; Ali Muhi; Tsutomu Araki
Journal:  Radiology       Date:  2010-07       Impact factor: 11.105

5.  Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.

Authors:  Young Joo Suh; Myeong-Jin Kim; Jin-Young Choi; Young Nyun Park; Mi-Suk Park; Ki Whang Kim
Journal:  AJR Am J Roentgenol       Date:  2011-07       Impact factor: 3.959

6.  Characterization of cirrhotic nodules with gadoxetic acid-enhanced magnetic resonance imaging: the efficacy of hepatocyte-phase imaging.

Authors:  Chen-Te Chou; Yao-Li Chen; Wei-Wen Su; Hwa-Koon Wu; Ran-Chou Chen
Journal:  J Magn Reson Imaging       Date:  2010-10       Impact factor: 4.813

7.  Uptake of Gd-EOB-DTPA by hepatocellular carcinoma: radiologic-pathologic correlation with special reference to bile production.

Authors:  Yoshiki Asayama; Tsuyoshi Tajima; Akihiro Nishie; Kousei Ishigami; Daisuke Kakihara; Tomohiro Nakayama; Daisuke Okamoto; Nobuhiro Fujita; Shinichi Aishima; Ken Shirabe; Hiroshi Honda
Journal:  Eur J Radiol       Date:  2010-11-24       Impact factor: 3.528

8.  Hepatocellular carcinoma: signal intensity at gadoxetic acid-enhanced MR Imaging--correlation with molecular transporters and histopathologic features.

Authors:  Azusa Kitao; Yoh Zen; Osamu Matsui; Toshifumi Gabata; Satoshi Kobayashi; Wataru Koda; Kazuto Kozaka; Norihide Yoneda; Tatsuya Yamashita; Shuichi Kaneko; Yasuni Nakanuma
Journal:  Radiology       Date:  2010-07-27       Impact factor: 11.105

9.  Comparison between Gd-DTPA, Gd-EOB-DTPA, and Mn-DPDP in induced HCC in rats: a correlation study of MR imaging, microangiography, and histology.

Authors:  G Marchal; X Zhang; Y Ni; P Van Hecke; J Yu; A L Baert
Journal:  Magn Reson Imaging       Date:  1993       Impact factor: 2.546

10.  Prolonged positive contrast enhancement with Gd-EOB-DTPA in experimental liver tumors: potential value in tissue characterization.

Authors:  Y Ni; G Marchal; J Yu; A Mühler; G Lukito; A L Baert
Journal:  J Magn Reson Imaging       Date:  1994 May-Jun       Impact factor: 4.813

View more
  4 in total

1.  Advanced liver imaging using MR to predict outcomes in chronic liver disease: a shift from morphology to function liver assessment.

Authors:  Francesco Verde; Valeria Romeo; Simone Maurea
Journal:  Quant Imaging Med Surg       Date:  2020-03

2.  Multiparametric imaging for detection and characterization of hepatocellular carcinoma using gadoxetic acid-enhanced MRI and perfusion-CT: which parameters work best?

Authors:  Mustafa Kurucay; Christopher Kloth; Sascha Kaufmann; Konstantin Nikolaou; Hans Bösmüller; Marius Horger; Wolfgang M Thaiss
Journal:  Cancer Imaging       Date:  2017-06-28       Impact factor: 3.909

3.  Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only-A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort.

Authors:  Max Seidensticker; Ingo G Steffen; Irene Bargellini; Thomas Berg; Alberto Benito; Bernhard Gebauer; Roberto Iezzi; Christian Loewe; Musturay Karçaaltincaba; Maciej Pech; Christian Sengel; Otto van Delden; Vincent Vandecaveye; Christoph J Zech; Jens Ricke
Journal:  Curr Oncol       Date:  2022-01-27       Impact factor: 3.677

4.  Optimization of hepatobiliary phase delay time of Gd-EOB-DTPA-enhanced magnetic resonance imaging for identification of hepatocellular carcinoma in patients with cirrhosis of different degrees of severity.

Authors:  Jian-Wei Wu; Yue-Cheng Yu; Xian-Li Qu; Yan Zhang; Hong Gao
Journal:  World J Gastroenterol       Date:  2018-01-21       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.